ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,523,656, issued on Jan. 13, was assigned to ShanghaiTech University (Shanghai) and ShOx Science Ltd. (Hong Kong).

"Antibodies against SARS-CoV-2 spike protein" was invented by Peixiang Ma (Shanghai), Guang Yang (Shanghai), Richard A. Lerner (Shanghai), Min Qiang (Shanghai) and Hou Wang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are human antibodies and fragments thereof having binding specificity to the SARS-CoV-2 spike protein's receptor binding domain (RBD). The antibodies and fragments have strong affinity and potent neutralization ability against the SARS-CoV-2 virus and various mutant forms. Also provided are trimeric antibod...